{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:23:35Z","timestamp":1788362615227,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Louis XIV\u2019s rapidly progressive terminal illness may be better explained by necrotizing soft-tissue infection than primary calciphylaxis. Severe distal pain, ascending gangrene, and fatal sepsis within three weeks suggest fulminant infection, plausibly arising from a diabetic foot lesion. Clinical chronology should remain central when evaluating competing retrospective clinicopathological hypotheses.<\/jats:p>","DOI":"10.1186\/s12882-026-05328-8","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:06:12Z","timestamp":1788361572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment - Louis XIV\u2019s terminal illness clinical chronology favors necrotizing soft-tissue infection"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2262-8523","authenticated-orcid":false,"given":"Alexis","family":"Demas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"5328_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12882-025-04053-y","volume":"26","author":"S Bataille","year":"2025","unstructured":"Bataille S, Charlier P. Revisiting the death of Louis XIV: a nephrological perspective. BMC Nephrol. 2025;26:146.","journal-title":"BMC Nephrol"},{"key":"5328_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1056\/NEJMra1600673","volume":"377","author":"DL Stevens","year":"2017","unstructured":"Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253\u201365.","journal-title":"N Engl J Med"},{"issue":"S1","key":"5328_CR3","doi-asserted-by":"publisher","first-page":"e3280","DOI":"10.1002\/dmrr.3280","volume":"36","author":"BA Lipsky","year":"2020","unstructured":"Lipsky BA, Senneville \u00c9, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes. Diabetes Metab Res Rev. 2020;36(S1):e3280.","journal-title":"Diabetes Metab Res Rev"},{"key":"5328_CR4","doi-asserted-by":"crossref","unstructured":"Demas A, Commentary on, Charlier et al. article Paleoproteomics reveals chromoblastomycosis as possible cause of King of France Louis XIV\u2019s death (1715). Ann Pharm Fr. 2026.","DOI":"10.1016\/j.pharma.2026.04.005"},{"key":"5328_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.anaerobe.2011.11.001","volume":"18","author":"DL Stevens","year":"2012","unstructured":"Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe. 2012;18:254\u20139.","journal-title":"Anaerobe"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05328-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:06:13Z","timestamp":1788361573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05328-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05328-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None. The author declare that there are no additional disclosures to report. The author confirms that the approval of an institutional review board was not required for this work.","order":3,"name":"Ethics","label":"Financial disclosures for the previous 12 months","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"518"}}